InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,306.04
(
0.00%
)
US TECH 100
18,225.60
(
-0.88%
)
Dow Jones
38,852.86
(
0.00%
)
Brent Oil
84.28
(
-0.06%
)
Bitcoin
67,787.53
(
-0.74%
)

Replies to post #130 on Crispr Therapeutics AG (CRSP)

Replies to #130 on Crispr Therapeutics AG (CRSP)

NY1972

06/07/22 8:51 AM

#131 RE: jondoeuk #130

Too bad GNCA NPT with CAR knock in + PD1 will never be tested. ACT with CART targeting multiple neoantigens will be as potent and more durable.